SCHEMBL999481

SCHEMBL999481

O=C1OC(=O)c2c1cccc2[S+]([O-])c1cccc2c1C(=O)OC2=O

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TYMS P04818 4/20 0.42
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087097 0.75 TDP1 (0.60) ALOX15TDP1TYMSALDH1A1
SCHEMBL31548711 0.75 TDP1 (0.60) ALOX15TDP1TYMSALDH1A1
Dimethyl Sulfoxide SCHEMBL28038423 0.72 MAOA (0.47) ALOX15TDP1TYMSALDH1A1
SCHEMBL30073249 0.71 TDP1 (0.48) ALOX15TDP1TYMSALDH1A1
SCHEMBL29539686 0.70 ALOX15 (0.52) ALOX15TDP1TYMSALDH1A1
SCHEMBL31416073 0.70 TDP1 (0.52) ALOX15TDP1TYMSALDH1A1
SCHEMBL19604974 0.70 TDP1 (0.52) ALOX15TDP1TYMSALDH1A1
SCHEMBL10502400 0.70 TDP1 (0.52) ALOX15TDP1TYMSALDH1A1
SCHEMBL166198 0.70 ALOX15 (0.52) ALOX15TDP1TYMSALDH1A1
SCHEMBL308375 0.70 TDP1 (0.52) ALOX15TDP1TYMSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863463-B2 Method of purifying dianhydrides SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-01-04 US claimed
US-7495113-B2 Method of purifying dianhydrides SABIC INNOVATIVE PLASTICS (US) 2009-02-24 US claimed
US-20070117990-A1 Method of purifying dianhydrides GENERAL ELECTRIC COMPANY (US) 2007-05-24 US claimed
US-20060135791-A1 Method of purifying dianhydrides GENERAL ELECTRIC COMPANY 2006-06-22 US claimed
US-7981996-B2 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-07-19 US disclosed
EP-1674443-B1 Method of purifying dianhydrides SABIC INNOVATIVE PLASTICS IP (NL) 2009-07-29 EP disclosed
US-7495113-B2 Method of purifying dianhydrides SABIC INNOVATIVE PLASTICS (US) 2009-02-24 US disclosed
US-20080119660-A1 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility GENERAL ELECTRIC COMPANY (US) 2008-05-22 US disclosed
EP-1674443-A1 Method of purifying dianhydrides The General Electric Company (US) 2006-06-28 EP disclosed
US-20060135791-A1 Method of purifying dianhydrides GENERAL ELECTRIC COMPANY 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119660-A1 reaction of a diamine such as ortho, meta or para-phenylenediamine with an anhydride like 3- or 4-chlorophthalic anhydride (3-ClPA) in the presence of a solvent (ortho dichlorobenzene) at a temperature above the normal boiling point of the solvent to produce bis/halophthalobisimide/; limited solubility DDT, DDC, DDAH1 ALOX15 2718/4885TDP1 279/4885TYMS 2091/4885
US-20070117990-A1 Method of purifying dianhydrides CA7, HDHD5, CA2 ALOX15 4790/4885TDP1 1591/4885TYMS 3734/4885
US-20060135791-A1 Method of purifying dianhydrides SAMHD1, TREH, DOHH ALOX15 4090/4885TDP1 2169/4885TYMS 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.